Risk aggregation in non-life insurance: Standard models vs. internal models
Martin Eling and
Kwangmin Jung
Insurance: Mathematics and Economics, 2020, vol. 95, issue C, 183-198
Abstract:
Standard models for capital requirements restrict the correlation between risk factors to the linear measure and disregard undertaking-specific parameters. We consider an alternative framework for risk aggregation in non-life insurance using vine copulas that allow non-linear dependence and are estimated with undertaking-specific parameters. We empirically compare our alternative risk model with three regulatory standard models (Korean risk-based capital, Solvency II, Swiss Solvency Test) and show that the standard models lead to more than 50% higher capital requirements on average. Half of the overestimation results from the uniform parameter selection imposed by regulations and the other half comes from the linear correlation assumption. The differences might distort competition when both standard models and internal risk models are used in a single market.
Keywords: Insurance regulation; Risk aggregation; Vine copula; Capital requirements; Internal Models (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S016766872030130X
Full text for ScienceDirect subscribers only
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:eee:insuma:v:95:y:2020:i:c:p:183-198
DOI: 10.1016/j.insmatheco.2020.09.003
Access Statistics for this article
Insurance: Mathematics and Economics is currently edited by R. Kaas, Hansjoerg Albrecher, M. J. Goovaerts and E. S. W. Shiu
More articles in Insurance: Mathematics and Economics from Elsevier
Bibliographic data for series maintained by Catherine Liu ().